Saturday, July 11, 2026

pharma · Hepatocellular Carcinoma · Obesity

Hospital Authority

Hospital Authority, Hong is a pharma organization headquartered in CN. Primary therapeutic focus areas include Hepatocellular Carcinoma, Obesity, Acute Kidney Injury, Nasopharyngeal Carcinoma, Coronary Artery Disease. No

Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong, 852, HK, CN HQ
1991 Founded
12,669 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Hospital Authority Building, 147B Argyle Street, Kowloon, Hong Kong, 852, HK, CN
Founded
1991
Employees
12,669
Programs
322
Drugs
301
Patents
0
Clinical program

Cordyceps cicadae extract

Phase 1 · mab · Myopia

Cordyceps cicadae extract for Myopia is a Phase 1 program (mab) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Internal code CRREC-111-087

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Hospital Authority, Hong Kong
Phase
Phase 1
Modality
mab
Indication
Myopia
Status
completed
Trials
1

Clinical trials